Mathias Locher
Corporate Officer/Principal presso Covagen AG
Provenienza dei contatti di primo grado di Mathias Locher
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland.
12
| Subsidiary | Medical Specialties | 12 |
Covagen AG
Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland.
7
| Subsidiary | Biotechnology | 7 |
Public Company | Pharmaceuticals: Major | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Mathias Locher tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
LOGITECH INTERNATIONAL S.A. | Computer Peripherals | Director of Finance/CFO | |
ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member | |
PQ Bypass, Inc.
PQ Bypass, Inc. Electronic Equipment/InstrumentsElectronic Technology PQ Bypass, Inc. develops novel procedure for the treatment of peripheral vascular diseases. It offers an approach for achieving a bypass of the femoral artery that is designed to match the performance and safety of an invasive surgery for long segment occlusions. The company was founded by Richard Heuser and James D. Joye in 2009 and is headquartered in Sunnyvale, CA. | Electronic Equipment/Instruments | Director/Board Member | |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Private Equity Investor | |
STALLERGENES | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Cortendo AB
Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA. | Miscellaneous Commercial Services | Director/Board Member | |
ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Corporate Officer/Principal | |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
University of Lund | College/University | Doctorate Degree | |
Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree | |
University College Cork | College/University | Doctorate Degree | |
Kernel Management Partners Ltd.
Kernel Management Partners Ltd. Investment ManagersFinance Kernel Management Partners Ltd. (Kernel Capital) is a venture capital firm founded in 1999 by Niall Olden. The firm is headquartered in Cork, Ireland. | Investment Managers | Private Equity Investor | |
Polytech Clermont-Ferrand | College/University | Doctorate Degree | |
Altimmune UK Ltd.
Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Stokes Bio Ltd.
Stokes Bio Ltd. BiotechnologyHealth Technology Stokes Bio Ltd. develops microfluidics technologies for gene expression measurement and target detection. It detects soft and solid tumors, and toxicology. The company was founded by Mark Davies, Tara Dalton and Edward M. Walsh in 2005 and is headquartered in Limerick, Ireland. | Biotechnology | Director/Board Member | |
FerroKin BioSciences, Inc.
FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Director/Board Member | |
Cilag GmbH International
Cilag GmbH International Pharmaceuticals: MajorHealth Technology Cilag GmbH International conducts and coordinates international business in the pharmaceutical, chemical, consumer goods, medical products, and food products sectors. It also engages in the management of the corresponding research and development, particularly with reference to trading with products in these sectors. The company was founded in 1984 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Chairman Chief Executive Officer Chief Executive Officer | |
UCD Michael Smurfit Graduate School of Business | College/University | Undergraduate Degree | |
Serono International SA | Corporate Officer/Principal | ||
Apica Cardiovascular Ltd.
Apica Cardiovascular Ltd. Medical SpecialtiesHealth Technology Apica Cardiovascular Ltd. designs and develops innovative medical devices for the treatment of cardiovascular diseases. Its product includes innovative transapical access and closure system that is designed to simplify and standardize the technique used to open and close the apex of a beating hear. The company was founded by Ajit P. Yoganathan, Jorge H. Jimenez, Vinod H. Thourani and James L. Greene in November 2009 and is headquartered in Galway, Ireland. | Medical Specialties | Director/Board Member | |
Luiss Business School | College/University | Masters Business Admin | |
Seroba BioVentures Ltd.
Seroba BioVentures Ltd. Investment ManagersFinance Seroba BioVentures Ltd (Seroba BioVentures) is a venture capital subsidiary of Kernel Management Partners Ltd founded in 2001 by Peter Sandys and Seamus O''Hara. The firm is headquartered in Dublin, Ireland. | Investment Managers | Private Equity Investor | |
Medlumics SL
Medlumics SL Medical SpecialtiesHealth Technology Medlumics SL provides medical imaging diagnostics services. It specializes in optically guided medical devices. The firm’s proprietary integrated optics platform technology combines optical and electrical components in a miniature chip, enabling for the first time complex multi view optical probes of the size of a grain of rice and ultra-portable, hand-held OCT systems that produces real-time images. The company was founded by Eduardo Margallo Balbás and Jose Luis Rubio Guivernau on April 3, 2009 and is headquartered in Tres Cantos, Spain. | Medical Specialties | Director/Board Member | |
Cardiorentis AG
Cardiorentis AG Pharmaceuticals: MajorHealth Technology Cardiorentis AG operates as a biopharmaceutical company. It offers novel therapies to the treatment of heart failure and related cardiovascular diseases. The company was founded in 2010 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Rainier Therapeutics, Inc.
Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Director/Board Member | |
WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Glionova AB
Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Actelion Clinical Research, Inc. | Director/Board Member | ||
Healthneed AB | Director/Board Member | ||
Atlantic Therapeutics Ltd.
Atlantic Therapeutics Ltd. Medical SpecialtiesHealth Technology Atlantic Therapeutics Ltd. is a medical device developer of non-invasive pelvic floor strengthening and nerve stimulation products. The firm offers INNOVO products. The company is headquartered in Galway, Ireland. | Medical Specialties | Director/Board Member | |
Zaluvida Corporate AG
Zaluvida Corporate AG BiotechnologyHealth Technology Part of Zaluvida Holdings Pte Ltd., Zaluvida Corporate AG operates as a Swiss biotechnology company. The company is based in Zurich, Switzerland. | Biotechnology | Director of Finance/CFO | |
Vivet Therapeutics SAS
Vivet Therapeutics SAS BiotechnologyHealth Technology Vivet Therapeutics SAS develops novel gene therapy treatments for inherited metabolic diseases. The firm offers its services under the categorizers of Biopharma, Biotechnology and Health Care. The company was founded by Jean-Philippe Combal, Gloria Gonzalez-Aseguinolaza and Jens Kurth on July 26, 2016 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Precirix NV
Precirix NV Pharmaceuticals: MajorHealth Technology Precirix NV develops and distributes radio-immunotherapeutic drugs for cancer patients. The company was founded on October 14, 2014 by Jens De Vos, Ludwig Camusot, Nick Devoogdt, Geert Raes, Tony Lahoutte and Matthias Dhuyvetter and is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
ADCendo ApS
ADCendo ApS BiotechnologyHealth Technology ADCendo ApS is a Danish company that is focused on developing antibody-drug conjugates (ADCs) to treat underserved cancers. The company is based in Humlebaek, Denmark. The company completed a series A extension financing round in 2023, which brought its funds to 82 million EUR to advance into clinical development. The investors in the company include Novo Holdings, Ysios Capital, Pontifax Venture Capital, RA Capital Management, HealthCap, and Gilde Healthcare. The company was founded in 2017 by Christoffer Nielsen, Henrik Stage. Michael Pehl has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Aro Biotherapeutics Co.
Aro Biotherapeutics Co. BiotechnologyHealth Technology Aro Biotherapeutics Co. operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics products. It specializes in oncology, drug discovery, drug development, licensing, drug delivery, sirna, immunology, bispecifics, protein conjugation, protein therapeutics and protein engineering services. The company was founded by Karyn O?Neil and Susan Dillon in 2018 and is headquartered in Philadelphia, PA. | Biotechnology | Director/Board Member | |
Kuste Biopharma SAS
Kuste Biopharma SAS Pharmaceuticals: MajorHealth Technology Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Priothera Ltd.
Priothera Ltd. BiotechnologyHealth Technology Priothera Ltd. engages in the development of orally delivered sphingosine-1-phosphate (S1P) receptor modulators for hematological malignancies. The company was founded by Florent Gros, Shaval Patel, and Brice Suire in 2020 and is headquartered in Dublin, Ireland. | Biotechnology | Director/Board Member | |
Hemab ApS
Hemab ApS BiotechnologyHealth Technology Hemab ApS develops antibodies for the treatment of rare bleeding disorders. The company is based in Copenhagen, Denmark. The Danish company was founded in 2019 by Johan Henrik Faber. Benny Sorensen has been the CEO of the company since 2020. | Biotechnology | Director/Board Member | |
FORM Life Ventures
FORM Life Ventures Investment ManagersFinance FORM Life (FORM Life ventures) is venture capital firm founded in 2022 by Markus Okumus. FORM Life Ventures is headquartered in Luxembourg. | Investment Managers | Consultant / Advisor | |
ViroCarb, Inc.
ViroCarb, Inc. Pharmaceuticals: MajorHealth Technology Virocarb Inc is a biotechnology company located in Canada that develops drugs for viral infections with critical unmet therapeutic needs. | Pharmaceuticals: Major | Chief Executive Officer | |
Mahzi Therapeutics, Inc.
Mahzi Therapeutics, Inc. BiotechnologyHealth Technology Mahzi Therapeutics is a private biotechnology company that focuses on genetic therapies for rare genetic neurodevelopmental disorders. The company was founded by Yael Weiss and is based in San Mateo, CA. The company unites patient and family groups, academic researchers, diagnostic companies, other industry members, and its internal team of experts to develop therapies for patients with these serious diseases. Mahzi's team is experienced in all aspects of biopharmaceutical research, development, and manufacturing and is driven to make a difference in the lives of patients with rare genetic diseases. Yael Weiss has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
O'mahony Holding Srl
O'mahony Holding Srl Real Estate DevelopmentFinance O'mahony Holding Srl is a Belgian company that provides purchase, sale, and rental of real estate services. The private company was founded in 2005 and is based in Brussels, Belgium. | Real Estate Development | Director/Board Member | |
STALLERGENES GREER | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO |
Statistiche
Distribuzione geografica
Stati Uniti | 12 |
Irlanda | 11 |
Svizzera | 7 |
Svezia | 7 |
Francia | 6 |
Settori
Health Technology | 33 |
Consumer Services | 7 |
Finance | 6 |
Electronic Technology | 3 |
Commercial Services | 2 |
Posizioni
Director/Board Member | 80 |
Corporate Officer/Principal | 34 |
Chairman | 27 |
Chief Executive Officer | 24 |
Independent Dir/Board Member | 14 |
Contatti più connessi
Insiders | |
---|---|
Frank Armstrong | 41 |
Elmar Schnee | 31 |
Marten Steen | 21 |
Peter Buhler | 14 |
Daniel O'Mahony | 12 |
Roberto Gradnik | 11 |
Olaf Klinger | 9 |
Bharat Tewarie | 9 |
Guy Braunstein | 8 |
Marc Funk | 8 |
Luigi Marro | 7 |
Timothy Donald Kneen | 6 |
Dong Zhou Liu | 5 |
David Bruce Bancroft | 3 |
Laurent Galibert | 3 |
- Borsa valori
- Insiders
- Mathias Locher
- Connessioni Società